Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:03:08 UTC
Update Date2022-09-22 18:34:22 UTC
HMDB IDHMDB0028959
Secondary Accession Numbers
  • HMDB28959
Metabolite Identification
Common NameLysylproline
DescriptionLysylproline is a dipeptide composed of lysine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Structure
Data?1582753359
Synonyms
ValueSource
KPChEBI
L-Lys-L-proChEBI
Lysyl-prolineChEBI
K-p DipeptideHMDB
KP DipeptideHMDB
L-Lysyl-L-prolineHMDB
Lys-proHMDB
Lysine proline dipeptideHMDB
Lysine-proline dipeptideHMDB
N-L-Lysyl-L-prolineHMDB
N-LysylprolineHMDB
LysylprolineChEBI
Chemical FormulaC11H21N3O3
Average Molecular Weight243.307
Monoisotopic Molecular Weight243.158291548
IUPAC Name(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carboxylic acid
Traditional Name(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carboxylic acid
CAS Registry Number52766-27-5
SMILES
NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O
InChI Identifier
InChI=1S/C11H21N3O3/c12-6-2-1-4-8(13)10(15)14-7-3-5-9(14)11(16)17/h8-9H,1-7,12-13H2,(H,16,17)/t8-,9-/m0/s1
InChI KeyAIXUQKMMBQJZCU-IUCAKERBSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Proline or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-l-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • N-acylpyrrolidine
  • Pyrrolidine carboxylic acid or derivatives
  • Pyrrolidine carboxylic acid
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Amino acid or derivatives
  • Carboxamide group
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Azacycle
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Organic oxide
  • Carbonyl group
  • Organopnictogen compound
  • Amine
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-3.35Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility20.7 g/LALOGPS
logP-3.1ALOGPS
logP-3.4ChemAxon
logS-1.1ALOGPS
pKa (Strongest Acidic)3.68ChemAxon
pKa (Strongest Basic)10.21ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area109.65 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity62.8 m³·mol⁻¹ChemAxon
Polarizability26.06 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+161.23630932474
DeepCCS[M-H]-158.87830932474
DeepCCS[M-2H]-191.76430932474
DeepCCS[M+Na]+167.32930932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.1.58 minutes32390414
Predicted by Siyang on May 30, 20229.1447 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20228.64 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid421.5 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid395.6 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid223.4 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid77.4 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid167.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid59.2 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid266.0 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid261.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)983.6 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid578.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid42.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid569.9 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid170.9 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid208.3 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate990.4 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA707.8 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water389.8 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LysylprolineNCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O3009.4Standard polar33892256
LysylprolineNCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O2430.3Standard non polar33892256
LysylprolineNCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O2241.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Lysylproline,1TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN2210.5Semi standard non polar33892256
Lysylproline,1TMS,isomer #2C[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O2347.2Semi standard non polar33892256
Lysylproline,1TMS,isomer #3C[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O2281.6Semi standard non polar33892256
Lysylproline,2TMS,isomer #1C[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2270.5Semi standard non polar33892256
Lysylproline,2TMS,isomer #1C[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2366.1Standard non polar33892256
Lysylproline,2TMS,isomer #2C[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2344.4Semi standard non polar33892256
Lysylproline,2TMS,isomer #2C[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2390.4Standard non polar33892256
Lysylproline,2TMS,isomer #3C[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2394.6Semi standard non polar33892256
Lysylproline,2TMS,isomer #3C[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2460.8Standard non polar33892256
Lysylproline,2TMS,isomer #4C[Si](C)(C)N(CCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2476.5Semi standard non polar33892256
Lysylproline,2TMS,isomer #4C[Si](C)(C)N(CCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2496.6Standard non polar33892256
Lysylproline,2TMS,isomer #5C[Si](C)(C)N([C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2388.4Semi standard non polar33892256
Lysylproline,2TMS,isomer #5C[Si](C)(C)N([C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2404.4Standard non polar33892256
Lysylproline,3TMS,isomer #1C[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2362.7Semi standard non polar33892256
Lysylproline,3TMS,isomer #1C[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2514.3Standard non polar33892256
Lysylproline,3TMS,isomer #2C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N([Si](C)(C)C)[Si](C)(C)C2405.4Semi standard non polar33892256
Lysylproline,3TMS,isomer #2C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N([Si](C)(C)C)[Si](C)(C)C2470.1Standard non polar33892256
Lysylproline,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN([Si](C)(C)C)[Si](C)(C)C2486.9Semi standard non polar33892256
Lysylproline,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN([Si](C)(C)C)[Si](C)(C)C2522.8Standard non polar33892256
Lysylproline,3TMS,isomer #4C[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2518.9Semi standard non polar33892256
Lysylproline,3TMS,isomer #4C[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2567.6Standard non polar33892256
Lysylproline,3TMS,isomer #5C[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C2501.4Semi standard non polar33892256
Lysylproline,3TMS,isomer #5C[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C2557.7Standard non polar33892256
Lysylproline,4TMS,isomer #1C[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2544.7Semi standard non polar33892256
Lysylproline,4TMS,isomer #1C[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2585.8Standard non polar33892256
Lysylproline,4TMS,isomer #2C[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2521.3Semi standard non polar33892256
Lysylproline,4TMS,isomer #2C[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2595.8Standard non polar33892256
Lysylproline,4TMS,isomer #3C[Si](C)(C)N(CCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2689.4Semi standard non polar33892256
Lysylproline,4TMS,isomer #3C[Si](C)(C)N(CCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2662.4Standard non polar33892256
Lysylproline,5TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2743.9Semi standard non polar33892256
Lysylproline,5TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2671.7Standard non polar33892256
Lysylproline,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN2475.3Semi standard non polar33892256
Lysylproline,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O2588.9Semi standard non polar33892256
Lysylproline,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O2542.9Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2786.8Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2734.8Standard non polar33892256
Lysylproline,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2826.7Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2795.4Standard non polar33892256
Lysylproline,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2893.9Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2828.6Standard non polar33892256
Lysylproline,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N(CCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2929.3Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N(CCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2874.5Standard non polar33892256
Lysylproline,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N([C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2851.0Semi standard non polar33892256
Lysylproline,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N([C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2809.1Standard non polar33892256
Lysylproline,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3092.9Semi standard non polar33892256
Lysylproline,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NCCCC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3019.2Standard non polar33892256
Lysylproline,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3089.6Semi standard non polar33892256
Lysylproline,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2992.8Standard non polar33892256
Lysylproline,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3151.1Semi standard non polar33892256
Lysylproline,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3073.1Standard non polar33892256
Lysylproline,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O3217.9Semi standard non polar33892256
Lysylproline,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O3124.3Standard non polar33892256
Lysylproline,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3214.8Semi standard non polar33892256
Lysylproline,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3104.0Standard non polar33892256
Lysylproline,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3444.6Semi standard non polar33892256
Lysylproline,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3265.6Standard non polar33892256
Lysylproline,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3431.0Semi standard non polar33892256
Lysylproline,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3250.2Standard non polar33892256
Lysylproline,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(CCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3535.2Semi standard non polar33892256
Lysylproline,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(CCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3366.1Standard non polar33892256
Lysylproline,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3750.2Semi standard non polar33892256
Lysylproline,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3462.4Standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Feces
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  2. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB111982
KNApSAcK IDNot Available
Chemspider ID149672
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound171204
PDB IDNot Available
ChEBI ID74567
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Kieliszewski MJ, Leykam JF, Lamport DT: Trypsin cleaves lysylproline in a hydroxyproline-rich glycoprotein from Zea mays. Pept Res. 1989 May-Jun;2(3):246-8. [PubMed:2520761 ]
  2. Nausch I, Heymann E: Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. J Neurochem. 1985 May;44(5):1354-7. [PubMed:2580948 ]
  3. Katinas GS, Petriaeva MA: [The dynamics of the reparative regeneration of the rat epidermis exposed to lysylproline]. Morfologiia. 1992 May;102(5):106-12. [PubMed:1285287 ]
  4. Karanewsky DS, Badia MC, Cushman DW, DeForrest JM, Dejneka T, Loots MJ, Perri MG, Petrillo EW Jr, Powell JR: (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE. J Med Chem. 1988 Jan;31(1):204-12. [PubMed:3336020 ]
  5. Marino AM, Chong S, Dando SA, Kripalani KJ, Bathala MS, Morrison RA: Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852. J Pharm Sci. 1996 Mar;85(3):282-6. [PubMed:8699329 ]